DET1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.367200E-01
Normal-vs-Stage2
2.702200E-01
Normal-vs-Stage3
1.681870E-02
Normal-vs-Stage4
6.112200E-01
Stage1-vs-Stage2
3.878200E-02
Stage1-vs-Stage3
2.478300E-02
Stage1-vs-Stage4
9.777800E-01
Stage2-vs-Stage3
2.060800E-01
Stage2-vs-Stage4
8.067700E-02
Stage3-vs-Stage4
5.780500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.252400E-01
Normal-vs-AfricanAmerican
3.059200E-01
Normal-vs-Asian
1.357570E-01
Caucasian-vs-AfricanAmerican
8.225400E-01
Caucasian-vs-Asian
1.342590E-01
AfricanAmerican-vs-Asian
2.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.830050E-01
Normal-vs-Female
4.406400E-01
Male-vs-Female
2.830800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.839000E-01
Normal-vs-Age(41-60Yrs)
5.680800E-01
Normal-vs-Age(61-80Yrs)
1.664440E-01
Normal-vs-Age(81-100Yrs)
1.531160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.925000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.856820E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.291600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.016020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.175800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.979200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.672300E-02
Normal-vs-Daily Drinker
2.084000E-01
Normal-vs-Weekly Drinker
6.018800E-01
Normal-vs-Occasional Drinker
5.401600E-01
Normal-vs-Social Drinker
4.846600E-01
Non Drinker-vs-Daily Drinker
6.040000E-01
Non Drinker-vs-Weekly Drinker
4.368000E-01
Non Drinker-vs-Occasional Drinker
2.413200E-01
Non Drinker-vs-Social Drinker
1.278040E-01
Daily Drinker-vs-Weekly Drinker
6.276200E-01
Daily Drinker-vs-Occasional Drinker
4.460200E-01
Daily Drinker-vs-Social Drinker
3.715200E-01
Weekly Drinker-vs-Occasional Drinker
9.411600E-01
Weekly Drinker-vs-Social Drinker
8.954000E-01
Occasional Drinker-vs-Social Drinker
9.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.175800E-01
Normal-vs-Grade 2
7.194400E-01
Normal-vs-Grade 3
7.442000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.391200E-01
Grade 1-vs-Grade 3
4.587000E-01
Grade 1-vs-Grade 4
7.175800E-01
Grade 2-vs-Grade 3
3.178200E-01
Grade 2-vs-Grade 4
7.194400E-01
Grade 3-vs-Grade 4
7.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.099600E-02
Normal-vs-NonDiabetic
3.770200E-01
Diabetic-vs-NonDiabetic
4.288000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.692400E-01
Normal-vs-NoPancreatitis
2.979600E-01
Pancreatitis-vs-NoPancreatitis
4.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.296000E-01
Normal-vs-N1
2.967200E-01
N0-vs-N1
6.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.900400E-01
Normal-vs-TP53-NonMutant
5.961800E-01
TP53-Mutant-vs-TP53-NonMutant
9.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
